| Name | | |
| Last NAV | 624.44 | 50.88 |
| Date of Valuation | 2025/10/10 | 2025/10/10 |
| Sharpe Ratio | 0.46 | N/A |
| 3-Year Risk Return Ratio | -0.16 | 0.92 |
| Cumulative Performance (%) |
| +19.71% | +13.02% |
| +36.51% | +31.57% |
| +86.04% | +54.60% |
| +41.56% | +29.63% |
| -25.77% | +17.29% |
| -10.53% | -17.36% |
| +4.44% | +33.53% |
| N/A | +408.80% |
| Calendar Year Performance (%) |
| -25.77% | +17.29% |
| -35.61% | -12.51% |
| -10.53% | -17.36% |
| +164.57% | +27.52% |
| +4.44% | +33.53% |
| 3-Year Annualised Volatility | 32.46% | 19.27% |
| Funds House | BNP Paribas Investment Partners - BNP Paribas L1 Funds | Franklin Templeton Investments (Asia) Ltd |
| Portfolio Manager | Ulrik FUGMANN & Edward LEES | Evan McCulloch & Wendy Lam & Akiva Felt |
| Funds Type | Equity Funds | Equity Funds |
| Funds Size | USD 1082025600 | USD 1590000000 |
| Base Currency | EUR | USD |
| Sector | Energy | Biotechnology |
| Geographic Allocation | Global | US |
| Top Holdings |
| FIRST SOLAR INC (6.19%) | AMGEN INC (8.16%) |
| FLUENCE ENERGY INC CLASS A A (5.62%) | REGENERON PHARMACEUTICALS INC (7.13%) |
| CAMECO CORP (5.51%) | VERTEX PHARMACEUTICALS INC (5.83%) |
| NVIDIA CORP (5.46%) | INSMED INC (3.82%) |
| VERTIV HOLDINGS CLASS A A (5.36%) | GILEAD SCIENCES INC (3.69%) |
| SIEMENS ENERGY N AG (5.23%) | ASTRAZENECA PLC (2.92%) |
| ARRAY TECHNOLOGIES INC (4.95%) | INTRA-CELLULAR THERAPIES INC (2.84%) |
| NVENT ELECTRIC PLC (4.58%) | BIOGEN INC (2.74%) |
| SUNRUN INC (4.35%) | MERUS NV (2.73%) |
| CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (3.64%) | ARGENX SE (2.68%) |
| Minimum Initial Investment | EUR 800 | USD 1000 |
| Initial Sales Fee | Up to 5% of the net asset value of the relevant share class subscribed | Class A: Up to 5.00%. Class B: Nil |
| Switching Fee | Up to 2% of the net asset value of the relevant share class converted | Class A: 1.00%. Class B: Nil |
| Maintenance Fee | Other fees:Up to 0.35%(Other fees cover the general asset custody expenses payable to the custodian and the daily administration expenses) | Custodian fee Class A: Up to 0.14% ( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Custodian fee Class B: Up to 0.14%( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Maintenance charge Class A: Up to 0.50%. Maintenance charge Class B: Up to 0.75%. Servicing charge Class A: Nil. Servicing charge Class B: 1.06%. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class A: Up to 0.2175%, Up to USD 30 per annum. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class B: Up to 0.2175%, Up to USD 30 per annum. |
| Redemption Fee | Nil | Class A: Nil. Class B: Up to 4.00% |
| Launch Date | 2013/05/17 | 2000/04/03 |
| End of Financial Year | 31/12 | 30/06 |
| Country of Registry | Luxembourg | Luxembourg |
| Other Relevant Information | | |
| |